Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Loaded Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) on Protein A Biosensor, can bind with Biotinylated Human IL-33, His,Avitag (Cat. No. IL3-H82H5) an affinity constant of 1.81 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tozorakimab | MEDI-3506 | Phase 3 Clinical | Medimmune | Pneumonia, Viral; Diabetic Nephropathies; Asthma; Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic; Dermatitis, Atopic | Details |
Itepekimab | REGN-3500; SAR-440340 | Phase 3 Clinical | Sanofi | Bronchiectasis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Etokimab | ANB-020 | Phase 2 Clinical | Anaptysbio Inc | Pulmonary Eosinophilia; Asthma; Sinusitis; Peanut Hypersensitivity; Hypersensitivity; Dermatitis, Atopic | Details |
MT-2990 | MT-2990 | Phase 2 Clinical | Mitsubishi Tanabe Pharma Corp | Pain; Rhinitis, Allergic, Seasonal; Vasculitis; Endometriosis | Details |
PF-07264660 | PF-07264660 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
PF-06817024 | PF-06817024 | Phase 1 Clinical | Pfizer Inc | Nose Diseases; Dermatitis, Atopic | Details |
SSGJ-621 | SSGJ-621; 621 | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
CAN-10 | CAN-10 | Phase 1 Clinical | Lund University Foundation | Scleroderma, Systemic; Psoriasis; Myocarditis; Plaque psoriasis | Details |
Torudokimab | LY-3375880 | Phase 1 Clinical | Eli Lilly And Company | Dermatitis, Atopic | Details |
GSK-3862995 | GSK-3862995; GSK3862995; GSK3862995B; GSK-3862995B | Phase 1 Clinical | Glaxosmithkline Plc | Pulmonary Disease, Chronic Obstructive | Details |
QX-007N | QX-007N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
Tozorakimab | MEDI-3506 | Phase 3 Clinical | Medimmune | Pneumonia, Viral; Diabetic Nephropathies; Asthma; Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic; Dermatitis, Atopic | Details |
Itepekimab | REGN-3500; SAR-440340 | Phase 3 Clinical | Sanofi | Bronchiectasis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Etokimab | ANB-020 | Phase 2 Clinical | Anaptysbio Inc | Pulmonary Eosinophilia; Asthma; Sinusitis; Peanut Hypersensitivity; Hypersensitivity; Dermatitis, Atopic | Details |
MT-2990 | MT-2990 | Phase 2 Clinical | Mitsubishi Tanabe Pharma Corp | Pain; Rhinitis, Allergic, Seasonal; Vasculitis; Endometriosis | Details |
PF-07264660 | PF-07264660 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
PF-06817024 | PF-06817024 | Phase 1 Clinical | Pfizer Inc | Nose Diseases; Dermatitis, Atopic | Details |
SSGJ-621 | SSGJ-621; 621 | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
CAN-10 | CAN-10 | Phase 1 Clinical | Lund University Foundation | Scleroderma, Systemic; Psoriasis; Myocarditis; Plaque psoriasis | Details |
Torudokimab | LY-3375880 | Phase 1 Clinical | Eli Lilly And Company | Dermatitis, Atopic | Details |
GSK-3862995 | GSK-3862995; GSK3862995; GSK3862995B; GSK-3862995B | Phase 1 Clinical | Glaxosmithkline Plc | Pulmonary Disease, Chronic Obstructive | Details |
QX-007N | QX-007N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
This web search service is supported by Google Inc.